Rizzo, A.; Racca, M.; Dall’Armellina, S.; Rescigno, P.; Banna, G.L.; Albano, D.; Dondi, F.; Bertagna, F.; Annunziata, S.; Treglia, G.
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers 2023, 15, 355.
https://doi.org/10.3390/cancers15020355
AMA Style
Rizzo A, Racca M, Dall’Armellina S, Rescigno P, Banna GL, Albano D, Dondi F, Bertagna F, Annunziata S, Treglia G.
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers. 2023; 15(2):355.
https://doi.org/10.3390/cancers15020355
Chicago/Turabian Style
Rizzo, Alessio, Manuela Racca, Sara Dall’Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, and Giorgio Treglia.
2023. "The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review" Cancers 15, no. 2: 355.
https://doi.org/10.3390/cancers15020355
APA Style
Rizzo, A., Racca, M., Dall’Armellina, S., Rescigno, P., Banna, G. L., Albano, D., Dondi, F., Bertagna, F., Annunziata, S., & Treglia, G.
(2023). The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers, 15(2), 355.
https://doi.org/10.3390/cancers15020355